114 results
Page 4 of 6
8-K
EX-99.1
mz70 hd1wp5d68nkkzf
25 Feb 21
Regulation FD Disclosure
7:01am
8-K
EX-1.1
uus8hakzhwf6bt
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
424B5
oqoz6
20 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
gtorvvzo2 f9rqe7lpr
19 Jan 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-4.2
0psu0f8v5oq3bt9jrc9
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
er4hfs2
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.1
b1zv hy9kd6wcdp
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.2
tl2z8 89y4uyry05ooq
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-4.1
mvl7mq9g3jjrm4m bk5
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
8df1laj1z8
26 Oct 20
Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral
6:10am
424B5
dry4yoh6g77 cyx
23 Jun 20
Prospectus supplement for primary offering
5:16pm